Natco Pharma's board of directors approved a major capital-raising plan on September 9, 2026.
2 reports, 1 independent
Updated Sep 9
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Natco Pharma's board of directors approved a major capital-raising plan on September 9, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Board of directors of Natco Pharma approved a major capital-raising plan.1 source
Interactive Financial Services Limited's board approved a fund-raising plan.1 source
Keep exploring
The entities involved
-
board of directors
group of people who jointly supervise the activities of an organization
-
Natco Pharma
Indian pharmaceutical company
Related events
- A company's board of directors approved an enhanced corporate and financing framework on July 24, 2026.
- Printcare PLC's board recommended a rights issue on September 1, 2026, to raise capital.
- Suryoday Small Finance Bank's board approved capital raising via Non-Convertible Debentures to meet Basel II requirements.
- A bank's board of directors provided oversight and strategic direction on May 26, 2026.
- Board of Directors of IIFL Finance Limited approved the allotment of Non-Convertible Debentures (NCD) on September 3, 2026.